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MinireviewAccounting for Specificity
in Receptor Tyrosine
Kinase Signaling
that saturating levels of ligand and overexpressed re-
ceptors were used (see review by Pawson and Saxton,
1999 for further discussion). Nonetheless, these highly
provocative data raised the question of how much spe-
cific information is being transmitted by the distinct sig-
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naling molecules activated by RTKs, and suggested that
the pathways may be functionally redundant (Figure 1A).Many signal transduction mechanisms transmit informa-
If this view is correct, RTK pathways may function merelytion from the extracellular space or an intracellular com-
to activate transcription factors generically, whose ac-partment to the nucleus where they influence gene ex-
tivities would determine the consequences of signalingpression. This flow can be viewed metaphorically as the
and whose identities would be specified by cell typereverse of gene expression where information moves
(Figure 1B). As the authors themselves pointed out, itoutward from the genome. However, the idea that signal
is important to extend these studies beyond laboratory-transduction processes convey detailed amounts of in-
adapted tissue culture cells (Fambrough et al., 1999).formation has been recently debated with respect to
Engineered animals offer an appropriate test since inreceptor tyrosine kinases (RTKs). Upon binding to their
principle ligands and receptors are expressed at physio-ligands, RTK molecules dimerize and undergo autophos-
logical levels and in the correct temporal pattern andphorylation on specific tyrosine residues. In turn, these
tissue context. Knockin studies in mice of the PDGFRphosphotyrosines and their adjacent sequences specifi-
described above have yielded some evidence for dis-cally recruit downstream signaling molecules via their
tinct functions for SH2 docking sites in vivo. Mice con-SH2 domains, causing their subsequent activation. The
taining a mutation in the PI-3K docking site were fully
activation of a single type of RTK thus leads to the
viable (in contrast to the null which dies during develop-
activation of multiple intracellular signal transduction
ment due to cardiovascular, renal, and hematological
pathways. The naı¨ve expectation would be that each
defects), but exhibited a defect in interstitial fluid ho-
pathway would have a distinct function. However, a
meostasis (Heuchel et al., 1999). A double mutant in the
number of studies have called this presumption into
PI-3K and PLC docking sites again resulted in viable
question. For example, a study of mutants of the plate- mice, but these showed a defect in vascular cell fitness
let-derived growth factor receptor RTK led to the sur- in chimeric mice (Tallquist et al., 2000). Studies in mice
prising conclusion that the downstream pathways are of other RTKs have also supported the view that the
in fact redundant in terms of what genes they activate docking sites are not totally redundant. For example,
(Fambrough et al., 1999). I will first focus on these mutation of PLC docking site of the essential FGFR1
thought-provoking cell culture experiments before de- RTK yields viable mice with a specific homeotic transfor-
scribing studies in whole animals that indicate that a mation (Partanen et al., 1998). The c-Kit RTK is required
significant amount of specific (i.e., nonredundant) infor- for normal hematopoesis, melanogenesis, and gameto-
mation can be transmitted during RTK signaling. genesis. Strikingly, mutation of the PI-3K docking site
To address whether distinct SH2 domain-containing of this receptor results in a specific defect in gametogen-
signaling molecules send qualitatively different signals, esis (Blume-Jensen et al., 2000; Kissel et al., 2000). Two
Fambrough et al. (1999) created mutations in SH2 bind- recent papers published in Molecular Cell inform further
ing sites in the platelet-derived growth factor  receptor the issue of RTK specificity using engineered mice.
(PDGFR). NIH 3T3 cells were transfected with con- In experiments by Klinghoffer and colleagues, the in-
structs encoding hybrid receptors with an intracellular tracellular domains of the  and  isoforms of the PDGF
domain from the PDGFR and the extracellular domain receptor (encoded by distinct genes) were exchanged
of the M-CSF receptor. Remarkably, simultaneous mu- to address the issue of RTK effector redundancy (Kling-
tation of five SH2 binding sites, which drastically re- hoffer et al., 2001). The experiment asked whether re-
duces the biological responsiveness of PDGFR func- placement of the PDGFR intracellular domain with that
tion in cultured cells, had only modest quantitative of  would result in a functional receptor as assayed in
effects on immediate-early gene inductions in response a knockin mouse. The reciprocal experiment was also
to the heterologous ligand M-CSF (which avoided acti- performed. While the two isoforms are known to bind
vation of endogenous PDGF receptors) as measured many of the same effectors such as Src, PI-3K, SHP-2,
by microarray hybridization. These data suggested that and PLC1, there are known distinctions. Unlike , the
none of the sites tested (those that bound PI-3K, Ras- PDGFR intracellular domain binds the SH2-SH3 adap-
GAP, SHP-2, and PLC) were essential for gene activa- tor protein Crk; in contrast,  can bind Ras-GAP as
well as a number of other signaling factors (reviewedtion. Since PGDFR is known to be phosphorylated on
in Heldin et al., 1998). Moreover, PDGFR promotes11 sites (reviewed in Heldin et al., 1998), nonredundant
particular cytoskeletal changes, calcium mobilization,roles in transcription may be played by signaling sites
chemotaxis, and oncogenic transformation to a greateron the receptor that were not mutated in this study
extent than the  isoform. Implicit in these experiments(Fambrough et al., 1999). Two caveats to the work are
is the notion that complementation or its failure would
be due to differences in the intracellular domains of the
two isoforms.1Correspondence: hiten@biochem.ucsf.edu
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authors focused on the Met RTK. Met binds the signaling
proteins PI-3K, Src, Grb2, Shc, Gab1, and others primar-
ily through two critical multifunctional docking sites (re-
viewed in Furge et al., 2000). Met is a receptor for hepa-
tocyte growth factor (HGF), also known as scatter factor,
and met/met null mice die during embryogenesis be-
cause of a defect in placenta formation and show loss
of hepatocyes, decreased muscle, and defects in axon
outgrowth and branching (see references in Maina et
al., 2001). Because of the complexity of the docking
sites, the authors attempted to create simpler alleles
of the receptor that would direct signaling to specific
pathways. The goal was to determine whether the ef-
fector pathways were redundant for the known functions
of Met. The authors introduced two SH2 binding site
mutations in the docking sites to bias them toward bind-
ing PI-3K (met2P), Src (met2S), or a change creating two
Figure 1. Models for Receptor Tyrosine Kinase Signaling Specificity
Grb2 binding sites (met2G). These mutations were
Shown is a generic RTK after ligand-induced dimerization, which
knocked in at the Met locus and homozygous mice werecauses the activation of three signaling pathways, “A,” ”B,” and
created (Maina et al., 2001). Maina and colleagues then“C.” “X,” “Y,” and “Z” represent distinct responses to these three
performed biochemical signaling studies of embryospathways. In panel (A), the signaling pathways are redundant re-
sulting in each activating the same responses, “X,” “Y,” and “Z.” In and hepatocytes from these mice, which confirmed that
panel (B), the pathways are redundant as in (A), except now, cell the alleles were biased in the predicted manner. How-
type refines the outcome of signaling such that outcomes “X” and ever, there were some exceptions, whose bases remain
“Y” occur in cell type 1 and outcomes “Y” and “Z” occur in cell to be investigated. First, the met2G allele displayed bind-
type 2. In panel (C), the distinct signaling pathways lead to distinct
ing to all three effectors. Moreover, each of the mutantresponses.
receptors displayed the ability to phosphorylate Gab1
and each exhibited some residual activation of the Ras-
MAPK pathway.The authors constructed two chimeras consisting of
As anticipated from its signaling properties, the met2Gthe ectodomain of one isoform and the intracellular do-
allele behaved as wild-type in a variety of assays (Mainamain of the other:  (i.e.,  ectodomain,  intracellular
et al., 2001). In contrast, the met2P allele was defectivedomain) and  (Klinghoffer et al., 2001). The  hybrid
in a subset of met functions (hepatocye survival in vivo,was then knocked into the  locus and the  hybrid
placental development, and myoblast migration), andwas knocked into the locus. Remarkably, both chimera
the met2S allele exhibited several phenotypes as wellknockins were viable, suggesting that the differences in
(hepatocyte survival, myoblast migration, and axon out-
signaling capability of the intracellular domains of the
growth and branching). Thus, these knockin experi-
two isoforms did not impact on overall survival. One
ments suggest that the pathways activated by Met are
interpretation of this result is that it is the shared ef-
not redundant, as the Src-biased and PI-3K-biased al-
fectors that bind both intracellular domains that are re- leles could each only complement a subset of the de-
sponsible for most of the receptors’ functions. The result fects seen in a mouse lacking met (Maina et al., 2001).
could equally be viewed as support for the redundancy Admittedly, the results of studies described are diffi-
of intracellular signaling pathways not shared by the two cult to compare directly because different receptors
isoforms. Upon closer inspection, however, the authors were analyzed, and the strategy for altering signaling
discovered that all was not well with the mutant mice. was distinct in each case. The cultured cell study left a
The / homozygous mice suffered from moderate number of signaling sites in the PDGFR cytoplasmic
cardiac hypertrophy and / hemizygous mice suffered domain intact and then mutated the remaining sites
from severe cardiac hypertrophy, glomerulosclerosis, (Fambrough et al., 1999). The in vivo studies of PDGFR,
and retinal detachment associated with a disorganized FGFR1, and c-Kit assayed single or double docking site
retinal vasculature. Interestingly,  produces a less mutations (Heuchel et al., 1999; Partanen et al., 1998;
sustained phosphorylation of MAP kinase than wild- Tallquist et al., 2000; Blume-Jensen et al., 2000; Kissel
type, suggesting a potential signaling defect that could et al., 2000) or the differences known to occur between
be responsible for these defects. Thus, while providing the two PDGFR isoforms (Klinghoffer et al., 2001). Again,
possible evidence for the redundancy model of RTK there exist signaling effectors that bind both isoforms,
effector output, the careful analysis performed by the making it difficult to interpret the wild-type phenotype
authors on the swaps suggests that there also is distinct of the  chimera PDGFR knockin. Studies of the Met
information being transmitted (Klinghoffer et al., 2001). RTK biased two multifunctional docking sites by site-
Because PDGFR contains a number of SH2 binding directed mutagenesis (Maina et al., 2001). Moreover,
sites not present in PDGFR, it is attractive to speculate immediate-early gene expression was used as the assay
that distinct effectors activated by PDGF are responsi- in one case (Fambrough et al., 1999), whereas the mouse
ble for the defects of the  chimera. studies utilized classical phenotypes. Expression profil-
A second recent knockin mouse study also suggests ing of the mutant mice would greatly inform the compari-
that signaling downstream of a RTK does not involve sons. Nonetheless, the lack of complementation seen
in the mouse with particular mutations suggests thatsolely redundant pathways (Maina et al., 2001). These
Minireview
11
signaling pathways induced by RTKs are not fully redun- complement of a simple eukaryote, such as budding
dant at the phenotypic level (Figure 1C). yeast (Goffeau et al., 1996; Lander et al., 2001; Venter
RTKs play key roles in Drosophila development and et al., 2001). In yeast, signaling pathways can afford
similar questions have been posed in this genetic model to be more dedicated or “hard-wired” such that each
system. An intriguing study identified developmental system transduces a specific signal to produce a spe-
mutations in the gene encoding the DSHC adaptor pro- cific output. Nonetheless, the question of precisely how
tein, a homolog of the mammalian SHC adaptor (Lusch- cells respond appropriately to signals in the face of
nig et al., 2000). dshc mutants are defective in signaling redundancy, cross-talk, and shared components in any
from the Torso and EGF RTKs but not from the Sevenless system remains open.
RTK, demonstrating that it functions within a subset of
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Two questions that can now be posed are why does
the amount of information delivered by RTK signaling
systems vary and, given the complexity of signaling,
how do cells respond appropriately? The answer to the
first question may be that in order for organisms with
large numbers of cell types to respond to signals, it is
advantageous to have a combination of specific infor-
mation being relayed by a signaling system with further
refinement by cell type. Combinatorial control that en-
compasses both signaling systems and transcription
factors may be necessary in a complex eukaryote, such
as a human, which has perhaps only six times the gene
